We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Elevated Platelet Tests Associated with Severe Heart Disease Risks

By LabMedica International staff writers
Posted on 13 Apr 2016
As a major component of the blood-vascular axis responsible for preventing hemorrhage, platelets (PLT) are crucial in the development of ischemic stroke due to its participation in thromboemboli that may initiate the symptoms of stroke. More...


Mean platelet volume (MPV) and PLT count are the two major parameters that reflect the functions and activities of PLTs. MPV, which describes the mean volume (size) of platelets, is an indicator that represents megakaryocytic hyperplasia and metabolism, and platelet production in bone marrow, and indicates the age of circulating platelets.

Scientists at Sichuan University (Chengdu, China) studied 281 first-time ischemic stroke and 164 first-time hemorrhagic stroke patients between 2010 and 2012. All participants received routine blood tests within two hours after admission and were categorized into good or poor prognosis group based on the Modified Rankin Scale (mRS) score. MPV and PLT count were measured within 30 minutes after venipuncture with a Sysmex XS-2000i autoanalyzer (Sysmex Corporation; Kobe, Japan).

The investigators found that the risk of ischemic and hemorrhagic stroke in MPV group of greater than 13 fL was 22.17 and 5.21 times higher compared with normal MPV group (9.4–12.5 fL). The PLT count was positively correlated with the risk of ischemic stroke, but negatively correlated with the risk of hemorrhagic stroke. MPV and PLT count was not correlated with the prognosis of either stroke. The findings showed that a decline in MPV reduced the risk of ischemic stroke whereas an elevated MPV increased the risk of ischemic stroke.

The authors concluded that increased MPV is an independent risk factor for both strokes. Elevated PLT count increases the risk for ischemic stroke, but decreases the risk for hemorrhagic stroke. However, neither MPV nor PLT count has significant association with the prognosis of either stroke. The study was published on March 19, 2016, in the International Journal of Laboratory Hematology.

Related Links:

Sichuan University 
Sysmex Corporation 



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.